Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.34 |
| ▸ | CXCL8 | P10145 | 3/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27837254 | 0.81 | TDP1 (0.44) | GAATP53HTTTDP1ALDH1A1 | |
| SCHEMBL31723959 | 0.81 | LPAR1 (0.34) | HTTTDP1ALDH1A1LPAR1KMT2A | |
| SCHEMBL4131377 | 0.78 | CXCR2 (0.45) | CXCR2ALDH1A1LPAR1KMT2AMAPT | |
| SCHEMBL2422660 | 0.78 | MAPK1 (0.54) | GAAHTTTDP1ALDH1A1KMT2A | |
| SCHEMBL29653879 | 0.78 | MAPK1 (0.54) | GAAHTTTDP1ALDH1A1KMT2A | |
| SCHEMBL1496397 | 0.77 | TP53 (0.42) | GAATP53CXCR2TDP1ALDH1A1 | |
| SCHEMBL7881974 | 0.75 | ALDH1A1 (0.44) | GAATP53CXCR2HTTTDP1 | |
| SCHEMBL31577354 | 0.75 | ALDH1A1 (0.44) | GAATP53CXCR2HTTTDP1 | |
| SCHEMBL31723401 | 0.74 | EGFR (0.38) | LPAR1KMT2ASMN1; SMN2LMNANLRP3 | |
| SCHEMBL16352522 | 0.74 | TDP1 (0.57) | GAACXCR2HTTTDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250351719-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2025-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250351719-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, PDCD2L | GAA 3347/4885TP53 1632/4885CXCR2 3278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.